ALBO

Albireo Pharma News

Kaufen
Verkaufen
Best deals to access real time data!
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
32,99 €
Trade Alert US
Monthly Subscription
for only
52,79 €
US Markets and Indices (NYSE/NASDAQ/AMEX)
Monthly Subscription
for only
15,62 €
VAT not included
Name Symbol Markt Aktientyp
Albireo Pharma Inc ALBO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-1,65 -7,01% 21,90 23:53:55
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
23,30 21,88 23,585 22,04 23,55
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.12.202112:15TRMNH.C. Wainwright Thinks Albireo Pharma’s Stock is Going to..
02.12.202114:30GLOBEAlbireo Expands Leadership with Constantine Chinoporos as..
19.11.202102:08TRMNThe Recent Pullback in These 2 Stocks Is a Buying..
12.11.202114:00GLOBEAlbireo Announces New Phase 3 Data for Bylvay™ (odevixibat)..
10.11.202114:30GLOBEAlbireo to Present at Upcoming Investor Conferences
04.11.202114:00EDGARQuarterly Report (10-q)
04.11.202113:47EDGARCurrent Report Filing (8-k)
04.11.202113:36SEEKAlbireo Pharma EPS beats by $2.41, misses on revenue
04.11.202113:30GLOBEAlbireo Reports Q3 Financial Results and Business Update
03.11.202114:52SEEKAlbireo Pharma Q3 2021 Earnings Preview
28.10.202114:30GLOBEAlbireo to Report Third Quarter 2021 Financial Results on..
26.10.202100:42EDGARStatement of Changes in Beneficial Ownership (4)
26.10.202100:31EDGARStatement of Changes in Beneficial Ownership (4)
15.10.202114:30GLOBEAlbireo to Showcase New Data at AASLD The Liver Meeting®..
12.10.202122:02EDGARStatement of Changes in Beneficial Ownership (4)
12.10.202114:30GLOBEAlbireo Announces Exclusive Licensing Agreement with Jadeite..
05.10.202114:30GLOBEAlbireo Recognizes PFIC Awareness Day 2021
28.9.202122:33EDGARStatement of Changes in Beneficial Ownership (4)
15.9.202114:30GLOBEAlbireo Announces Bylvay® (odevixibat) Now Available in..
08.9.202122:30GLOBEAlbireo Reports Inducement Grant Under Nasdaq Listing Rule..
08.9.202114:30GLOBEAlbireo Receives UK MHRA Approval of Bylvay® (odevixibat)
07.9.202114:55EDGARCurrent Report Filing (8-k)
07.9.202114:30GLOBEAlbireo Sells Priority Review Voucher (PRV) for $105 Million
02.9.202114:30GLOBEAlbireo to Present at Upcoming Investor Conferences
05.8.202115:04EDGARQuarterly Report (10-q)
05.8.202114:30GLOBEAlbireo Reports Q2 Financial Results and Business Update
05.8.202114:16EDGARCurrent Report Filing (8-k)
03.8.202114:30GLOBEAlbireo to Present at the 2021 Wedbush PacGrow Virtual..
29.7.202114:30GLOBEAlbireo to Report Second Quarter 2021 Financial Results on..
26.7.202122:06EDGARStatement of Changes in Beneficial Ownership (4)
21.7.202112:01EDGARCurrent Report Filing (8-k)
20.7.202123:21GLOBEMULTIMEDIA UPDATE - Albireo Announces FDA Approval of..
20.7.202122:00GLOBEAlbireo Announces FDA Approval of Bylvay™ (odevixibat), the..
20.7.202121:47SEEKAlbireo Pharma wins FDA approval for liver disease therapy
19.7.202114:25SEEKAlbireo's Bylvay OK'd in Europe for rare liver disease in..
19.7.202114:01GLOBEAlbireo Receives European Marketing Authorization of Bylvay™..
08.7.202114:30GLOBEAlbireo to Present at the William Blair Biotech Focus..
28.6.202122:53EDGARStatement of Changes in Beneficial Ownership (4)
28.6.202122:14EDGARStatement of Changes in Beneficial Ownership (4)
28.6.202122:13EDGARStatement of Changes in Beneficial Ownership (4)
28.6.202122:06EDGARStatement of Changes in Beneficial Ownership (4)
28.6.202122:05EDGARStatement of Changes in Beneficial Ownership (4)
28.6.202122:04EDGARStatement of Changes in Beneficial Ownership (4)
28.6.202122:02EDGARStatement of Changes in Beneficial Ownership (4)
24.6.202114:00GLOBEAlbireo to Present at Piper Sandler’s Virtual EASL Takeaway..
21.6.202122:16EDGARCurrent Report Filing (8-k)
21.6.202112:38SEEKAlbireo reports expanded data on Bylvay and A3907 at EASL..
21.6.202112:00GLOBEAlbireo Announces Expanded Phase 3 Data on..
10.6.202114:30GLOBEAlbireo to Showcase New Data at the EASL International Liver..
03.6.202122:30GLOBENew Phase 3 Data at WCPGHAN Show Long-Term Safety,..
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
NASDAQ
ALBO
Albireo Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20211203 23:30:16